Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Guangzhou Wanglaoji Health Industry Co. Ltd. is currently navigating 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is being processed by a distinct examiner in a distinct art unit. GEORGIANA C REGLAS is the busiest examiner for the company, overseeing the 1 pending office action currently in the pipeline. This single-point prosecution requires a focused approach to address the specific requirements of the assigned examiner.
The concentration of the company's current activity in the Biotechnology & Pharmaceuticals sector suggests a specialized patent strategy. With the pending office action, the company can focus its administrative and legal resources on this individual matter. GEORGIANA C REGLAS is the sole official managing the current workload, which simplifies the communication and negotiation process. This focused environment within a distinct art unit allows for a dedicated prosecution effort that is not distracted by the varying demands of multiple concurrent applications or different examiner styles.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGLAS, GEORGIANA C | 1 | 39.2% | +33.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18629960 | METHOD AND SYSTEM FOR SIMULTANEOUSLY EXTRACTING POLYSACCHARIDES, POLYPHENOLS, SOD AND VC OF ROSA ROXBURGHII TRATT FROM ROSA ROXBURGHII TRATT POMACE | REGLAS, GEORGIANA C | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18629960 | METHOD AND SYSTEM FOR SIMULTANEOUSLY EXTRACTING POLYSACCHARIDES, POLYPHENOLS, SOD AND VC OF ROSA ROXBURGHII TRATT FROM ROSA ROXBURGHII TRATT POMACE | REGLAS, GEORGIANA C | 1651 | §103 | Non-Final OA | — | Pending | Apr 09, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGuangzhou Wanglaoji Health Industry Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Georgiana C Reglas has the most, with 1 of Guangzhou Wanglaoji Health Industry Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
